238 related articles for article (PubMed ID: 33476865)
21. Synthesis of novel aryl-substituted 2-aminopyridine derivatives by the cascade reaction of 1,1-enediamines with vinamidinium salts to develop novel anti-Alzheimer agents.
Loori S; Pourtaher H; Mehranpour A; Hasaninejad A; Eftekharian M; Iraji A
Sci Rep; 2024 Jun; 14(1):13780. PubMed ID: 38877034
[TBL] [Abstract][Full Text] [Related]
22. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea.
Gezegen H; Gürdere MB; Dinçer A; Özbek O; Koçyiğit ÜM; Taslimi P; Tüzün B; Budak Y; Ceylan M
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000334. PubMed ID: 33300644
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
[TBL] [Abstract][Full Text] [Related]
28. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Kumar A; Pintus F; Di Petrillo A; Medda R; Caria P; Matos MJ; Viña D; Pieroni E; Delogu F; Era B; Delogu GL; Fais A
Sci Rep; 2018 Mar; 8(1):4424. PubMed ID: 29535344
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
[TBL] [Abstract][Full Text] [Related]
30. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
31. Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.
Kanhed AM; Sinha A; Machhi J; Tripathi A; Parikh ZS; Pillai PP; Giridhar R; Yadav MR
Bioorg Chem; 2015 Aug; 61():7-12. PubMed ID: 26042530
[TBL] [Abstract][Full Text] [Related]
32. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
[TBL] [Abstract][Full Text] [Related]
33. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
34. Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies.
Shah MS; Najam-Ul-Haq M; Shah HS; Farooq Rizvi SU; Iqbal J
Comput Biol Chem; 2018 Oct; 76():310-317. PubMed ID: 30142564
[TBL] [Abstract][Full Text] [Related]
35. Exploring enzyme inhibition profiles of novel halogenated chalcone derivatives on some metabolic enzymes: Synthesis, characterization and molecular modeling studies.
Anil DA; Polat MF; Saglamtas R; Tarikogullari AH; Alagoz MA; Gulcin I; Algul O; Burmaoglu S
Comput Biol Chem; 2022 Oct; 100():107748. PubMed ID: 35917597
[TBL] [Abstract][Full Text] [Related]
36. 5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer's disease modifying agents.
Yazdani M; Edraki N; Badri R; Khoshneviszadeh M; Iraji A; Firuzi O
Mol Divers; 2020 Aug; 24(3):641-654. PubMed ID: 31327094
[TBL] [Abstract][Full Text] [Related]
37. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
38. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
Lee S; Youn K; Lim G; Lee J; Jun M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932100
[TBL] [Abstract][Full Text] [Related]
39. A new series of pyridazinone derivatives as cholinesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies.
Özçelik AB; Özdemir Z; Sari S; Utku S; Uysal M
Pharmacol Rep; 2019 Dec; 71(6):1253-1263. PubMed ID: 31675671
[TBL] [Abstract][Full Text] [Related]
40. Ionic liquid mediated synthesis of mono- and bis-spirooxindole-hexahydropyrrolidines as cholinesterase inhibitors and their molecular docking studies.
Kia Y; Osman H; Kumar RS; Basiri A; Murugaiyah V
Bioorg Med Chem; 2014 Feb; 22(4):1318-28. PubMed ID: 24461561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]